Results 231 to 240 of about 5,124 (246)

Idarucizumab

2021
openaire   +1 more source

Idarucizumab

Reactions Weekly, 2019
openaire   +2 more sources

Sonorheometry parameters during dabigatran reversal with idarucizumab for major bleeding.

Journal of Pharmacology and Experimental Therapeutics
D. Teissandier, Rousseau Geoffroy, Lucchini Camille, Teulade Boris, Joly Camille, Schmidt Jeannot, Pereira Bruno, Lebreton Aurélien, Moustafa Farès   +8 more
semanticscholar   +1 more source

Idarucizumab and andexanet alfa may cause death

Reactions weekly

semanticscholar   +1 more source

Idarucizumab

Reactions Weekly, 2018
openaire   +2 more sources

Interference with immunofixation in a dabigatran-overdosed patient treated with idarucizumab: beware of a diagnostic pitfall

Clinical Chemistry and Laboratory Medicine
Quentin Pomorski, M. Delrue, Ellias Bato, Mayssa Selmi, Bruno Mégarbane, Georges Jourdi, Virginie Siguret   +6 more
semanticscholar   +1 more source

Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study

American Journal of Cardiovascular Drugs, 2022
Langjing Huang, Zhihua Yu, Mei Liu, X. Shang   +3 more
semanticscholar   +1 more source

Dabigatran etexilate/idarucizumab

Reactions Weekly, 2019
  +4 more sources

Idarucizumab for Dabigatran Reversal Guideline

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2016
David P, Reardon, Kent, Owusu
openaire   +2 more sources

Dabigatran etexilate/idarucizumab

Reactions Weekly, 2021
openaire   +1 more source